Dorman Products (NASDAQ: DORM) reported Q3 EPS of $1.18, $0.04 worse than the analyst estimate of $1.22. Revenue for the quarter came in at $348.4 million versus the consensus estimate of $329.89 million.

GUIDANCE:

Dorman Products sees FY2021 EPS of $4.56-$4.80, versus the consensus of $4.67. Dorman Products sees FY2021 revenue of $1.3-1.33 billion, versus the consensus of $1.27 billion.

For earnings history and earnings-related data on Dorman Products (DORM) click here.